Diabetes – it’s good for the economy
Well it’s good for Big Pharma and their shareholders anyway. Why do I say that? Well just look at the recent $5.3bn acquisition of Amylin Pharmaceuticals Inc. by Bristol-Myers Squibb and AstraZeneca. Amylin produce diabetes drugs Byetta and Bydureon. It is estimated that they will need to make $2bn in peak sales to justify the transaction. Byetta made $518m in sales last year and Bydureon $7m in the first quarter of the year being only approved for sale in January. So looking at the figures they are going to have to do some hard selling to get their money back! Indeed Bristol executives said that while Amylin’s sales force had targeted endocrinologists, the combined sales forces of the three companies would be able to widen their presence to cover primary care physicians.
One endocrinologist I’ve mentioned in previous posts is Dr Robert Lustig who has stated that the lack of fibre in our modern diet combined with too much sugar (and high-fructose corn syrup) is the cause of obesity and diabetes. He believes you can cure type 2 diabetes in a week with a high-fibre diet. But do you think Big Pharma actually cares about this endocrinologists opinion. Hell no. At the end of the day these companies are raking in the profits as more and more people become ill through their poor diet. It’s the same for the food industry. It’s been shown that their lobbying of governments and other agencies forces them to water-down or even shelve reports that would hurt their business. Have a look at these articles where the sugar industry threatened the WHO (World Health Organisation) over a report they drafted recommending reducing a persons sugar intake:
And guess what happened? Yup the WHO recommendations were dropped – check out the video 9 mins in:
Also check out YouTube for all the episodes of The Men Who Made Us Fat – not on BBC iplayer anymore.